Abstract
This chapter on the EU regulatory perspective of the intravenous immunoglobulins (IVIGs) encompasses the following topics:
– Regulatory framework for IVIGs;
– Current EMEA initiatives: revision of the core SPC/IVIG Guideline;
– Paediatric Regulation: impacts/outcomes;
– Patient involvement and consultation in the EMEA activities.
Get full access to this article
View all access options for this article.